TScan Therapeutics is harnessing novel T cell systems to extend the promise of immunotherapy. TScan went public in July 2021 (NASDAQ: TCRX).
Biotech
Healthcare
AI
Details
- Founded
- 2018
- Partnered
- 2018
- Status
- Public (IPO)
- Ticker symbol
- NASDAQ: TCRX
TScan Therapeutics is harnessing novel T cell systems to extend the promise of immunotherapy. TScan went public in July 2021 (NASDAQ: TCRX).
Subscribe to get our research
the moment it’s released.
AI has widened the gap between a great leader and an average one. Five functional trends are evolving the C-suite—and here’s how CEOs can find the executives best equipped for what's next.
Enterprise decision-making is scaling more accurately and efficiently with AI-simulated populations.
Perfect GEO/AEO attribution doesn’t exist. The marketing leaders getting ahead are building their measurement stacks and moving anyway.
